| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 63 | 2021 | 560 | 8.660 |
Why?
|
| Cognition Disorders | 19 | 2015 | 496 | 2.970 |
Why?
|
| Athletic Injuries | 23 | 2025 | 529 | 2.850 |
Why?
|
| Brain Concussion | 23 | 2025 | 574 | 2.510 |
Why?
|
| Brain | 35 | 2017 | 2668 | 2.460 |
Why?
|
| Aldehydes | 17 | 2012 | 145 | 2.260 |
Why?
|
| Hippocampus | 25 | 2017 | 895 | 1.700 |
Why?
|
| Amyloid beta-Peptides | 15 | 2017 | 220 | 1.610 |
Why?
|
| Lipid Peroxidation | 16 | 2015 | 153 | 1.520 |
Why?
|
| Oxidative Stress | 16 | 2009 | 1317 | 1.490 |
Why?
|
| Zinc | 9 | 2012 | 297 | 1.480 |
Why?
|
| Football | 7 | 2024 | 85 | 1.310 |
Why?
|
| Neurons | 24 | 2010 | 1590 | 1.290 |
Why?
|
| DNA Damage | 10 | 2013 | 420 | 1.270 |
Why?
|
| Neuropsychological Tests | 21 | 2025 | 1023 | 1.110 |
Why?
|
| Acrolein | 7 | 2010 | 23 | 1.050 |
Why?
|
| DNA | 11 | 2013 | 1459 | 1.030 |
Why?
|
| Aged, 80 and over | 41 | 2017 | 7635 | 0.960 |
Why?
|
| Cerebral Cortex | 11 | 2017 | 433 | 0.940 |
Why?
|
| Micrognathism | 1 | 2024 | 18 | 0.890 |
Why?
|
| Disease Progression | 9 | 2017 | 2757 | 0.880 |
Why?
|
| Humans | 204 | 2025 | 137585 | 0.830 |
Why?
|
| Brain Chemistry | 5 | 2012 | 117 | 0.810 |
Why?
|
| Cation Transport Proteins | 7 | 2009 | 134 | 0.810 |
Why?
|
| Soccer | 2 | 2024 | 42 | 0.790 |
Why?
|
| Volleyball | 1 | 2022 | 10 | 0.770 |
Why?
|
| Male | 117 | 2025 | 67762 | 0.770 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 660 | 0.760 |
Why?
|
| Guanine | 6 | 2011 | 79 | 0.750 |
Why?
|
| Oxidation-Reduction | 15 | 2013 | 1060 | 0.750 |
Why?
|
| Prealbumin | 2 | 2015 | 30 | 0.740 |
Why?
|
| Lipocalins | 2 | 2015 | 36 | 0.740 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2015 | 68 | 0.740 |
Why?
|
| Nerve Tissue Proteins | 7 | 2013 | 596 | 0.700 |
Why?
|
| Athletes | 10 | 2024 | 423 | 0.700 |
Why?
|
| Female | 115 | 2025 | 73304 | 0.700 |
Why?
|
| Biliary Atresia | 5 | 2024 | 163 | 0.670 |
Why?
|
| Cell Nucleus | 8 | 2013 | 620 | 0.670 |
Why?
|
| 5-Methylcytosine | 2 | 2017 | 22 | 0.660 |
Why?
|
| Carrier Proteins | 4 | 2012 | 771 | 0.660 |
Why?
|
| DNA, Mitochondrial | 5 | 2015 | 200 | 0.640 |
Why?
|
| Hirschsprung Disease | 4 | 2025 | 88 | 0.640 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2016 | 66 | 0.630 |
Why?
|
| Iron | 6 | 2007 | 313 | 0.620 |
Why?
|
| Cerebellum | 6 | 2013 | 224 | 0.610 |
Why?
|
| Parahippocampal Gyrus | 3 | 2013 | 9 | 0.600 |
Why?
|
| Immunohistochemistry | 19 | 2013 | 1738 | 0.590 |
Why?
|
| Neurocalcin | 1 | 2017 | 1 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2024 | 3566 | 0.560 |
Why?
|
| Calcium Channel Blockers | 2 | 2016 | 167 | 0.560 |
Why?
|
| Rats | 23 | 2021 | 5647 | 0.560 |
Why?
|
| Dementia | 5 | 2017 | 259 | 0.550 |
Why?
|
| Aged | 45 | 2022 | 23961 | 0.540 |
Why?
|
| Parenteral Nutrition | 4 | 2025 | 107 | 0.540 |
Why?
|
| Craniocerebral Trauma | 4 | 2024 | 170 | 0.510 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 2607 | 0.510 |
Why?
|
| Cerebral Ventricles | 4 | 2008 | 52 | 0.510 |
Why?
|
| Pick Disease of the Brain | 2 | 2006 | 3 | 0.500 |
Why?
|
| Plaque, Amyloid | 5 | 2011 | 15 | 0.500 |
Why?
|
| Astrocytes | 3 | 2017 | 210 | 0.490 |
Why?
|
| Lipid Peroxides | 2 | 2015 | 10 | 0.480 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2024 | 279 | 0.480 |
Why?
|
| Liver | 7 | 2025 | 1943 | 0.480 |
Why?
|
| Neurofibrillary Tangles | 8 | 2011 | 13 | 0.480 |
Why?
|
| Blotting, Western | 11 | 2012 | 1226 | 0.470 |
Why?
|
| Amyloid | 1 | 2016 | 87 | 0.470 |
Why?
|
| Cognitive Dysfunction | 3 | 2015 | 383 | 0.460 |
Why?
|
| Liver Diseases | 4 | 2025 | 315 | 0.460 |
Why?
|
| DNA Glycosylases | 3 | 2011 | 8 | 0.450 |
Why?
|
| Animals | 48 | 2025 | 36940 | 0.450 |
Why?
|
| Rectum | 4 | 2025 | 185 | 0.440 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 8 | 2021 | 132 | 0.440 |
Why?
|
| Peptide Fragments | 4 | 2016 | 706 | 0.440 |
Why?
|
| Sleep | 3 | 2025 | 755 | 0.430 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 194 | 0.430 |
Why?
|
| Hydrogen Peroxide | 3 | 2007 | 328 | 0.430 |
Why?
|
| Kidney Neoplasms | 7 | 2021 | 403 | 0.430 |
Why?
|
| Neuroblastoma | 7 | 2017 | 160 | 0.420 |
Why?
|
| Cholestasis | 4 | 2022 | 235 | 0.420 |
Why?
|
| Mitochondria | 7 | 2018 | 948 | 0.420 |
Why?
|
| Antioxidants | 6 | 2023 | 584 | 0.410 |
Why?
|
| Alagille Syndrome | 2 | 2024 | 33 | 0.410 |
Why?
|
| Nerve Degeneration | 4 | 2018 | 46 | 0.400 |
Why?
|
| DNA Methylation | 2 | 2017 | 643 | 0.390 |
Why?
|
| DNA Repair | 4 | 2007 | 231 | 0.390 |
Why?
|
| Brain Injuries | 1 | 2017 | 494 | 0.390 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2012 | 10 | 0.390 |
Why?
|
| Biomarkers | 13 | 2024 | 4149 | 0.380 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2022 | 60 | 0.370 |
Why?
|
| Glutamates | 1 | 2012 | 59 | 0.370 |
Why?
|
| Case-Control Studies | 9 | 2017 | 3556 | 0.360 |
Why?
|
| Aluminum | 7 | 2000 | 42 | 0.360 |
Why?
|
| Cells, Cultured | 15 | 2012 | 4193 | 0.350 |
Why?
|
| Infant | 32 | 2025 | 9465 | 0.350 |
Why?
|
| Child | 37 | 2024 | 21935 | 0.330 |
Why?
|
| Infant, Newborn | 17 | 2025 | 6079 | 0.330 |
Why?
|
| Aging | 5 | 2012 | 1864 | 0.320 |
Why?
|
| Mass Spectrometry | 7 | 2021 | 739 | 0.320 |
Why?
|
| Portoenterostomy, Hepatic | 3 | 2018 | 46 | 0.320 |
Why?
|
| Biopsy | 9 | 2025 | 1129 | 0.310 |
Why?
|
| Naphthyridines | 2 | 2021 | 19 | 0.310 |
Why?
|
| Organoselenium Compounds | 1 | 2009 | 11 | 0.310 |
Why?
|
| Cell Survival | 10 | 2015 | 1120 | 0.310 |
Why?
|
| Adolescent | 31 | 2025 | 21513 | 0.310 |
Why?
|
| Prenatal Diagnosis | 3 | 2024 | 201 | 0.310 |
Why?
|
| Predictive Value of Tests | 5 | 2025 | 2031 | 0.310 |
Why?
|
| Glutathione Transferase | 4 | 2009 | 106 | 0.300 |
Why?
|
| Mutation | 11 | 2018 | 3958 | 0.300 |
Why?
|
| Retrospective Studies | 23 | 2025 | 15657 | 0.300 |
Why?
|
| Immunoprecipitation | 3 | 2017 | 155 | 0.300 |
Why?
|
| Temporal Lobe | 2 | 2006 | 91 | 0.300 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2004 | 49 | 0.290 |
Why?
|
| Autopsy | 6 | 2015 | 95 | 0.290 |
Why?
|
| Presenilin-1 | 3 | 2016 | 31 | 0.280 |
Why?
|
| Diagnosis, Differential | 11 | 2025 | 1483 | 0.280 |
Why?
|
| RNA | 3 | 2011 | 921 | 0.270 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 257 | 0.270 |
Why?
|
| Selenomethionine | 1 | 2007 | 4 | 0.270 |
Why?
|
| Head and Neck Neoplasms | 3 | 2024 | 606 | 0.260 |
Why?
|
| Recovery of Function | 4 | 2024 | 653 | 0.260 |
Why?
|
| tau Proteins | 3 | 2007 | 90 | 0.250 |
Why?
|
| Postmortem Changes | 3 | 2015 | 17 | 0.250 |
Why?
|
| Colon | 3 | 2025 | 282 | 0.250 |
Why?
|
| Nifedipine | 2 | 2016 | 29 | 0.250 |
Why?
|
| RNA, Messenger | 3 | 2011 | 2833 | 0.240 |
Why?
|
| Students | 4 | 2024 | 622 | 0.240 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 2018 | 18 | 0.230 |
Why?
|
| Oxidoreductases | 4 | 2003 | 92 | 0.230 |
Why?
|
| Proteome | 1 | 2010 | 472 | 0.230 |
Why?
|
| DNA Adducts | 3 | 2013 | 17 | 0.230 |
Why?
|
| Deoxyguanosine | 4 | 2007 | 25 | 0.230 |
Why?
|
| Liver Failure, Acute | 1 | 2025 | 67 | 0.230 |
Why?
|
| Skull Neoplasms | 2 | 2015 | 23 | 0.230 |
Why?
|
| Post-Concussion Syndrome | 2 | 2024 | 175 | 0.230 |
Why?
|
| Polyhydramnios | 1 | 2024 | 17 | 0.230 |
Why?
|
| Child, Preschool | 22 | 2025 | 11074 | 0.230 |
Why?
|
| Esophagitis | 2 | 2019 | 67 | 0.230 |
Why?
|
| RNA-Binding Proteins | 2 | 2005 | 422 | 0.220 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 82 | 0.220 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 135 | 0.220 |
Why?
|
| Proteomics | 3 | 2009 | 1111 | 0.220 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2024 | 285 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 1999 | 50 | 0.220 |
Why?
|
| Hemangioma | 1 | 2024 | 48 | 0.220 |
Why?
|
| Genes, Tumor Suppressor | 4 | 1999 | 86 | 0.220 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2024 | 63 | 0.220 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 4295 | 0.220 |
Why?
|
| Transfection | 3 | 2016 | 945 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 852 | 0.210 |
Why?
|
| Teratoma | 3 | 2017 | 114 | 0.210 |
Why?
|
| Genes, Wilms Tumor | 1 | 2003 | 1 | 0.210 |
Why?
|
| Hepatoblastoma | 2 | 2022 | 46 | 0.210 |
Why?
|
| Copper-transporting ATPases | 3 | 2009 | 6 | 0.210 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 40 | 0.210 |
Why?
|
| Apolipoprotein E4 | 3 | 2015 | 37 | 0.210 |
Why?
|
| Thioctic Acid | 1 | 2003 | 11 | 0.210 |
Why?
|
| Longitudinal Studies | 5 | 2023 | 2844 | 0.210 |
Why?
|
| Return to Sport | 1 | 2024 | 97 | 0.210 |
Why?
|
| Time Factors | 10 | 2024 | 6828 | 0.200 |
Why?
|
| Membrane Proteins | 3 | 2018 | 1164 | 0.200 |
Why?
|
| Sports | 4 | 2023 | 231 | 0.200 |
Why?
|
| Feeding Behavior | 1 | 2009 | 654 | 0.200 |
Why?
|
| Free Radicals | 4 | 2008 | 110 | 0.200 |
Why?
|
| Headache Disorders | 1 | 2023 | 18 | 0.200 |
Why?
|
| Enterocolitis | 1 | 2023 | 17 | 0.200 |
Why?
|
| Young Adult | 15 | 2024 | 13209 | 0.200 |
Why?
|
| Analysis of Variance | 6 | 2013 | 1316 | 0.200 |
Why?
|
| Lymphadenopathy | 1 | 2022 | 10 | 0.200 |
Why?
|
| Histiocytosis, Sinus | 1 | 2022 | 8 | 0.200 |
Why?
|
| Myositis | 1 | 2023 | 52 | 0.200 |
Why?
|
| Amygdala | 3 | 1998 | 191 | 0.200 |
Why?
|
| Cerebrospinal Fluid | 2 | 2004 | 92 | 0.200 |
Why?
|
| Granuloma | 1 | 2023 | 92 | 0.200 |
Why?
|
| Translocation, Genetic | 10 | 2004 | 105 | 0.200 |
Why?
|
| Airway Obstruction | 1 | 2024 | 162 | 0.200 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 325 | 0.200 |
Why?
|
| Mitochondrial Diseases | 3 | 2024 | 91 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 3 | 2009 | 168 | 0.190 |
Why?
|
| Neck | 3 | 2022 | 101 | 0.190 |
Why?
|
| Pulmonary Atresia | 1 | 2022 | 21 | 0.190 |
Why?
|
| Intestine, Small | 2 | 2002 | 156 | 0.190 |
Why?
|
| Copper | 2 | 2004 | 104 | 0.190 |
Why?
|
| Reproducibility of Results | 8 | 2025 | 3284 | 0.190 |
Why?
|
| Nuclear Warfare | 1 | 2002 | 10 | 0.190 |
Why?
|
| Point-of-Care Testing | 1 | 2022 | 32 | 0.190 |
Why?
|
| Follow-Up Studies | 9 | 2017 | 5131 | 0.190 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2002 | 11 | 0.190 |
Why?
|
| Coronary Circulation | 1 | 2022 | 143 | 0.190 |
Why?
|
| Intellectual Disability | 1 | 2023 | 165 | 0.190 |
Why?
|
| Electrophoresis, Capillary | 1 | 2021 | 20 | 0.190 |
Why?
|
| Migraine Disorders | 1 | 2023 | 102 | 0.180 |
Why?
|
| Abdominal Neoplasms | 2 | 2017 | 39 | 0.180 |
Why?
|
| Phytosterols | 1 | 2021 | 12 | 0.180 |
Why?
|
| Appendix | 1 | 2021 | 30 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2013 | 2057 | 0.180 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 2167 | 0.180 |
Why?
|
| Apoptosis | 3 | 2006 | 2553 | 0.180 |
Why?
|
| Computed Tomography Angiography | 1 | 2022 | 129 | 0.180 |
Why?
|
| Pulmonary Blastoma | 1 | 2021 | 8 | 0.180 |
Why?
|
| Sarcoidosis | 1 | 2023 | 159 | 0.170 |
Why?
|
| Glutathione Peroxidase | 3 | 2009 | 43 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 2486 | 0.170 |
Why?
|
| Glutamic Acid | 2 | 2000 | 246 | 0.170 |
Why?
|
| Ribonuclease III | 1 | 2021 | 40 | 0.170 |
Why?
|
| Schwann Cells | 1 | 2020 | 34 | 0.170 |
Why?
|
| Stem Cells | 1 | 2005 | 594 | 0.170 |
Why?
|
| Anemia, Aplastic | 1 | 2021 | 38 | 0.170 |
Why?
|
| Hepatitis | 1 | 2021 | 48 | 0.170 |
Why?
|
| Glutathione Reductase | 3 | 2009 | 25 | 0.170 |
Why?
|
| Coronary Vessels | 1 | 2022 | 248 | 0.170 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2002 | 115 | 0.170 |
Why?
|
| Epidermal Cyst | 1 | 2020 | 11 | 0.170 |
Why?
|
| Dermoid Cyst | 1 | 2020 | 15 | 0.170 |
Why?
|
| Enema | 1 | 2020 | 47 | 0.170 |
Why?
|
| Coronary Angiography | 1 | 2022 | 317 | 0.170 |
Why?
|
| Lipoproteins | 1 | 2021 | 168 | 0.170 |
Why?
|
| Maze Learning | 3 | 2017 | 103 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 167 | 0.170 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 76 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 527 | 0.170 |
Why?
|
| Mouth Diseases | 1 | 2020 | 45 | 0.170 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2000 | 13 | 0.160 |
Why?
|
| Avian Proteins | 1 | 2000 | 21 | 0.160 |
Why?
|
| Phosphorylation | 1 | 2004 | 1759 | 0.160 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 58 | 0.160 |
Why?
|
| Melanosis | 1 | 2020 | 16 | 0.160 |
Why?
|
| Thioredoxins | 1 | 2000 | 30 | 0.160 |
Why?
|
| Endodermal Sinus Tumor | 2 | 2014 | 9 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2007 | 976 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 413 | 0.160 |
Why?
|
| Antigens, Surface | 1 | 2000 | 154 | 0.160 |
Why?
|
| Fecal Incontinence | 1 | 2020 | 86 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 220 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 2 | 1999 | 217 | 0.160 |
Why?
|
| Electron Transport Complex I | 3 | 2017 | 41 | 0.160 |
Why?
|
| Fasciitis | 2 | 2023 | 12 | 0.160 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2019 | 10 | 0.160 |
Why?
|
| Neuroprotective Agents | 3 | 1999 | 131 | 0.160 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2019 | 14 | 0.160 |
Why?
|
| Ligases | 1 | 1999 | 32 | 0.150 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 19 | 0.150 |
Why?
|
| Vaginal Neoplasms | 3 | 2005 | 18 | 0.150 |
Why?
|
| Diseases in Twins | 2 | 2016 | 169 | 0.150 |
Why?
|
| Cardiomyopathies | 2 | 2017 | 350 | 0.150 |
Why?
|
| Neurogenesis | 1 | 2020 | 149 | 0.150 |
Why?
|
| Lymph Nodes | 2 | 2020 | 491 | 0.150 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 156 | 0.150 |
Why?
|
| Heterotaxy Syndrome | 1 | 2018 | 14 | 0.150 |
Why?
|
| Cholangitis | 1 | 2018 | 21 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 786 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 2 | 2017 | 286 | 0.150 |
Why?
|
| Esophagus | 2 | 2012 | 255 | 0.150 |
Why?
|
| Neuropil | 1 | 1998 | 1 | 0.150 |
Why?
|
| Anal Canal | 1 | 2019 | 97 | 0.150 |
Why?
|
| DNA Helicases | 1 | 2000 | 145 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 362 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 350 | 0.140 |
Why?
|
| Tracheal Neoplasms | 1 | 2018 | 9 | 0.140 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 62 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 2691 | 0.140 |
Why?
|
| Adenine | 3 | 2011 | 271 | 0.140 |
Why?
|
| Blood Proteins | 1 | 2000 | 252 | 0.140 |
Why?
|
| Pregnancy | 5 | 2025 | 6763 | 0.140 |
Why?
|
| Protein Kinases | 2 | 1999 | 319 | 0.140 |
Why?
|
| Proteins | 3 | 2004 | 1009 | 0.140 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2017 | 14 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1999 | 175 | 0.140 |
Why?
|
| Ubiquitin | 1 | 2017 | 70 | 0.140 |
Why?
|
| Point Mutation | 2 | 2016 | 235 | 0.140 |
Why?
|
| Thymus Neoplasms | 2 | 2010 | 25 | 0.140 |
Why?
|
| Biological Transport, Active | 2 | 2012 | 77 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2021 | 691 | 0.140 |
Why?
|
| Thymoma | 2 | 2010 | 36 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2000 | 319 | 0.140 |
Why?
|
| Body Fluids | 1 | 1997 | 66 | 0.140 |
Why?
|
| Infant Nutrition Disorders | 1 | 2017 | 11 | 0.130 |
Why?
|
| Coccyx | 1 | 2017 | 4 | 0.130 |
Why?
|
| Catalytic Domain | 1 | 2018 | 207 | 0.130 |
Why?
|
| Choledochal Cyst | 1 | 2017 | 19 | 0.130 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2017 | 22 | 0.130 |
Why?
|
| Choroid Neoplasms | 1 | 2017 | 7 | 0.130 |
Why?
|
| Leukemoid Reaction | 1 | 2016 | 3 | 0.130 |
Why?
|
| NADH Dehydrogenase | 1 | 2017 | 19 | 0.130 |
Why?
|
| Selenium | 1 | 2017 | 43 | 0.130 |
Why?
|
| Paraganglioma | 1 | 2018 | 52 | 0.130 |
Why?
|
| Biopsy, Needle | 6 | 2016 | 189 | 0.130 |
Why?
|
| Nervous System Diseases | 2 | 2011 | 266 | 0.130 |
Why?
|
| GATA1 Transcription Factor | 1 | 2016 | 18 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2000 | 521 | 0.130 |
Why?
|
| Anorexia | 1 | 2016 | 17 | 0.130 |
Why?
|
| Germinal Center | 1 | 2017 | 58 | 0.130 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 95 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 327 | 0.130 |
Why?
|
| Vitamin E | 1 | 2017 | 124 | 0.130 |
Why?
|
| Acidosis, Lactic | 1 | 2017 | 46 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2021 | 597 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 2 | 2017 | 16 | 0.130 |
Why?
|
| Adult | 15 | 2024 | 37929 | 0.130 |
Why?
|
| Calcineurin | 1 | 2017 | 108 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2022 | 7604 | 0.130 |
Why?
|
| Presenilin-2 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Synapsins | 1 | 2016 | 14 | 0.130 |
Why?
|
| Synaptophysin | 1 | 2016 | 14 | 0.130 |
Why?
|
| Sacrum | 1 | 2017 | 67 | 0.130 |
Why?
|
| Granuloma, Plasma Cell | 2 | 2008 | 13 | 0.130 |
Why?
|
| Logistic Models | 3 | 2016 | 2074 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2017 | 77 | 0.130 |
Why?
|
| Appetite | 1 | 2016 | 69 | 0.130 |
Why?
|
| Trachea | 1 | 2018 | 237 | 0.120 |
Why?
|
| Mice | 13 | 2021 | 17787 | 0.120 |
Why?
|
| Labial Frenum | 1 | 1995 | 3 | 0.120 |
Why?
|
| Early Diagnosis | 2 | 2015 | 242 | 0.120 |
Why?
|
| Brachytherapy | 1 | 2017 | 121 | 0.120 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 64 | 0.120 |
Why?
|
| Hemangioma, Cavernous | 1 | 2015 | 15 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2014 | 1692 | 0.120 |
Why?
|
| Hyperthermia, Induced | 1 | 2017 | 116 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2017 | 86 | 0.120 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1995 | 30 | 0.120 |
Why?
|
| Infant, Premature, Diseases | 1 | 2017 | 101 | 0.120 |
Why?
|
| Age Factors | 4 | 2018 | 3295 | 0.120 |
Why?
|
| Reference Values | 6 | 2013 | 816 | 0.120 |
Why?
|
| Membrane Potentials | 1 | 2016 | 284 | 0.120 |
Why?
|
| Electric Stimulation | 1 | 2016 | 264 | 0.120 |
Why?
|
| Glucose | 1 | 2000 | 1020 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 849 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2009 | 810 | 0.120 |
Why?
|
| Lasers | 4 | 1998 | 130 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2017 | 730 | 0.120 |
Why?
|
| Chromatography, Liquid | 3 | 2006 | 433 | 0.120 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.120 |
Why?
|
| Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.120 |
Why?
|
| Syndactyly | 1 | 2014 | 9 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2005 | 100 | 0.120 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 2 | 2010 | 11 | 0.110 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2015 | 19 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 2014 | 32 | 0.110 |
Why?
|
| Electron Transport | 3 | 2018 | 115 | 0.110 |
Why?
|
| Hamartoma | 1 | 2014 | 22 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2014 | 27 | 0.110 |
Why?
|
| Headache | 3 | 2023 | 147 | 0.110 |
Why?
|
| Bronchogenic Cyst | 1 | 2014 | 7 | 0.110 |
Why?
|
| Medical Marijuana | 1 | 2016 | 117 | 0.110 |
Why?
|
| Parotid Neoplasms | 3 | 1999 | 16 | 0.110 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 1995 | 121 | 0.110 |
Why?
|
| Heterozygote | 2 | 2014 | 293 | 0.110 |
Why?
|
| Sex Factors | 4 | 2025 | 2071 | 0.110 |
Why?
|
| Patient Preference | 1 | 2016 | 191 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 99 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2009 | 532 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 247 | 0.110 |
Why?
|
| Antibody Specificity | 2 | 2005 | 189 | 0.110 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 30 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2021 | 5742 | 0.110 |
Why?
|
| Nerve Net | 1 | 2017 | 256 | 0.110 |
Why?
|
| Kentucky | 2 | 2012 | 39 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2022 | 871 | 0.110 |
Why?
|
| Tissue Distribution | 4 | 2005 | 332 | 0.110 |
Why?
|
| Tetrazolium Salts | 2 | 2012 | 17 | 0.110 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2013 | 8 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2014 | 83 | 0.110 |
Why?
|
| Amantadine | 1 | 2013 | 7 | 0.100 |
Why?
|
| Dopamine Agents | 1 | 2013 | 19 | 0.100 |
Why?
|
| Papilloma | 2 | 2005 | 52 | 0.100 |
Why?
|
| Gene Rearrangement | 4 | 2004 | 150 | 0.100 |
Why?
|
| Lewy Body Disease | 1 | 2013 | 29 | 0.100 |
Why?
|
| Thiazoles | 2 | 2012 | 123 | 0.100 |
Why?
|
| ROC Curve | 1 | 2015 | 554 | 0.100 |
Why?
|
| Frontotemporal Dementia | 1 | 2013 | 57 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2021 | 10811 | 0.100 |
Why?
|
| Karyotyping | 8 | 2007 | 104 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2006 | 622 | 0.100 |
Why?
|
| Mucositis | 1 | 2012 | 19 | 0.100 |
Why?
|
| Mastoid | 1 | 2012 | 13 | 0.100 |
Why?
|
| Hybrid Cells | 4 | 1999 | 49 | 0.100 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2012 | 6 | 0.090 |
Why?
|
| Kupffer Cells | 1 | 2012 | 50 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 169 | 0.090 |
Why?
|
| Fatal Outcome | 6 | 2010 | 303 | 0.090 |
Why?
|
| Endoscopy | 1 | 2014 | 318 | 0.090 |
Why?
|
| Coloring Agents | 1 | 2012 | 87 | 0.090 |
Why?
|
| Cell Line | 3 | 2015 | 2847 | 0.090 |
Why?
|
| Fibrosis | 3 | 2023 | 552 | 0.090 |
Why?
|
| Prosencephalon | 2 | 2004 | 48 | 0.090 |
Why?
|
| Splenomegaly | 1 | 2011 | 15 | 0.090 |
Why?
|
| Incidence | 4 | 2021 | 2804 | 0.090 |
Why?
|
| Hemoglobin SC Disease | 1 | 2011 | 13 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 494 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 1457 | 0.090 |
Why?
|
| Syndrome | 2 | 2023 | 358 | 0.090 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2010 | 6 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2014 | 399 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 82 | 0.090 |
Why?
|
| Decision Making | 2 | 2009 | 900 | 0.090 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2010 | 14 | 0.090 |
Why?
|
| Succinate-CoA Ligases | 1 | 2010 | 4 | 0.090 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2010 | 7 | 0.090 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 74 | 0.090 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Rhabdoid Tumor | 2 | 2007 | 99 | 0.090 |
Why?
|
| Constipation | 2 | 2023 | 94 | 0.080 |
Why?
|
| Cytosol | 1 | 2011 | 226 | 0.080 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 1 | 2010 | 4 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 283 | 0.080 |
Why?
|
| Calcium | 4 | 2001 | 1199 | 0.080 |
Why?
|
| Middle Aged | 16 | 2017 | 33479 | 0.080 |
Why?
|
| Down Syndrome | 1 | 2016 | 496 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2021 | 762 | 0.080 |
Why?
|
| Liver Cirrhosis | 2 | 2022 | 316 | 0.080 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2010 | 30 | 0.080 |
Why?
|
| Abdominal Pain | 1 | 2011 | 145 | 0.080 |
Why?
|
| Lymphangioma | 1 | 2009 | 7 | 0.080 |
Why?
|
| Tonsillar Neoplasms | 1 | 2009 | 11 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 273 | 0.080 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 42 | 0.080 |
Why?
|
| Polyps | 1 | 2009 | 11 | 0.080 |
Why?
|
| Neoplasm Proteins | 3 | 2006 | 434 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2010 | 87 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2010 | 308 | 0.080 |
Why?
|
| Neoplasm Seeding | 1 | 1989 | 7 | 0.080 |
Why?
|
| Superoxide Dismutase | 2 | 2006 | 346 | 0.080 |
Why?
|
| Palatine Tonsil | 1 | 2009 | 48 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2010 | 213 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 136 | 0.080 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1989 | 30 | 0.080 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2008 | 6 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2010 | 325 | 0.080 |
Why?
|
| Prognosis | 2 | 2015 | 4030 | 0.080 |
Why?
|
| Intestines | 1 | 2012 | 357 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2015 | 922 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2017 | 1993 | 0.070 |
Why?
|
| Cytosine | 2 | 2006 | 49 | 0.070 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2008 | 26 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2010 | 140 | 0.070 |
Why?
|
| Pedigree | 3 | 2018 | 514 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2006 | 180 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 1989 | 93 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2008 | 57 | 0.070 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2008 | 41 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3412 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2004 | 1719 | 0.070 |
Why?
|
| Flow Cytometry | 5 | 2006 | 1178 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 209 | 0.070 |
Why?
|
| Neutrophils | 2 | 2010 | 1238 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 1329 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2010 | 218 | 0.070 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2012 | 325 | 0.070 |
Why?
|
| RNA, Transfer, Glu | 1 | 2007 | 6 | 0.070 |
Why?
|
| Lymphoma | 1 | 1989 | 208 | 0.070 |
Why?
|
| Calcinosis | 3 | 2000 | 235 | 0.070 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2008 | 63 | 0.070 |
Why?
|
| Spinal Cord | 2 | 2004 | 370 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 510 | 0.070 |
Why?
|
| Glutathione | 4 | 2023 | 356 | 0.070 |
Why?
|
| Ultrasonography | 4 | 2020 | 759 | 0.070 |
Why?
|
| Salivary Gland Neoplasms | 2 | 1999 | 41 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2010 | 843 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2008 | 89 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2526 | 0.070 |
Why?
|
| Biomarkers, Tumor | 3 | 2004 | 1276 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 523 | 0.070 |
Why?
|
| Mesenchymoma | 1 | 2007 | 8 | 0.070 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2007 | 12 | 0.070 |
Why?
|
| Radiography | 3 | 2015 | 822 | 0.070 |
Why?
|
| Cell Death | 2 | 2007 | 374 | 0.070 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2007 | 25 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2007 | 96 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2006 | 234 | 0.070 |
Why?
|
| Leukemia | 1 | 1989 | 240 | 0.070 |
Why?
|
| Uracil | 1 | 2006 | 31 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 889 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 163 | 0.070 |
Why?
|
| Bile Acids and Salts | 1 | 2008 | 200 | 0.070 |
Why?
|
| Kidney Diseases | 2 | 2001 | 408 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 2828 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2007 | 83 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 431 | 0.060 |
Why?
|
| Gonadoblastoma | 1 | 2006 | 6 | 0.060 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2006 | 14 | 0.060 |
Why?
|
| Eosinophils | 1 | 2009 | 332 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2006 | 565 | 0.060 |
Why?
|
| Combined Modality Therapy | 4 | 2017 | 1236 | 0.060 |
Why?
|
| Nucleic Acids | 1 | 2007 | 71 | 0.060 |
Why?
|
| Cell Fractionation | 2 | 2011 | 56 | 0.060 |
Why?
|
| trans-Golgi Network | 1 | 2006 | 13 | 0.060 |
Why?
|
| Twins, Monozygotic | 2 | 2016 | 203 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 1079 | 0.060 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2006 | 25 | 0.060 |
Why?
|
| Urinary Retention | 1 | 2006 | 21 | 0.060 |
Why?
|
| Injury Severity Score | 2 | 2021 | 522 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 265 | 0.060 |
Why?
|
| Women's Health | 1 | 2008 | 372 | 0.060 |
Why?
|
| Turner Syndrome | 1 | 2006 | 54 | 0.060 |
Why?
|
| Diagnosis | 1 | 2005 | 13 | 0.060 |
Why?
|
| History, Ancient | 1 | 2005 | 54 | 0.060 |
Why?
|
| Cell Count | 1 | 2006 | 324 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 1946 | 0.060 |
Why?
|
| Lactate Dehydrogenases | 1 | 2004 | 5 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 59 | 0.060 |
Why?
|
| Haplotypes | 1 | 2007 | 494 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 112 | 0.060 |
Why?
|
| Cuprizone | 1 | 2004 | 16 | 0.060 |
Why?
|
| Medulloblastoma | 1 | 2007 | 193 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 156 | 0.060 |
Why?
|
| Endosomes | 1 | 2006 | 136 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2008 | 346 | 0.060 |
Why?
|
| Muscle Neoplasms | 1 | 2024 | 8 | 0.060 |
Why?
|
| Lateral Ventricles | 2 | 2004 | 35 | 0.060 |
Why?
|
| Glioma | 1 | 1989 | 395 | 0.060 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2004 | 12 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2004 | 75 | 0.060 |
Why?
|
| Proto-Oncogenes | 1 | 2004 | 29 | 0.060 |
Why?
|
| Risk Factors | 5 | 2018 | 10388 | 0.060 |
Why?
|
| Phenotype | 4 | 2023 | 3196 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2010 | 1710 | 0.050 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2004 | 8 | 0.050 |
Why?
|
| Biological Transport | 1 | 2005 | 418 | 0.050 |
Why?
|
| Tubulin | 1 | 2005 | 144 | 0.050 |
Why?
|
| Memory | 2 | 2013 | 248 | 0.050 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2003 | 4 | 0.050 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2004 | 16 | 0.050 |
Why?
|
| Staurosporine | 1 | 2003 | 20 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1996 | 59 | 0.050 |
Why?
|
| England | 1 | 2023 | 97 | 0.050 |
Why?
|
| Youth Sports | 1 | 2024 | 35 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2003 | 4 | 0.050 |
Why?
|
| Cytochromes | 1 | 2003 | 10 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2004 | 36 | 0.050 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2003 | 20 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2003 | 81 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2004 | 50 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2003 | 18 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 385 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2005 | 189 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 44 | 0.050 |
Why?
|
| Dysbiosis | 1 | 2025 | 181 | 0.050 |
Why?
|
| Electron Transport Complex IV | 1 | 2003 | 60 | 0.050 |
Why?
|
| Testicular Diseases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 955 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 19 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 94 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 363 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2002 | 164 | 0.050 |
Why?
|
| Immunoglobulin J-Chains | 1 | 2002 | 6 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 26 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2002 | 10 | 0.050 |
Why?
|
| Sports Medicine | 1 | 2004 | 112 | 0.050 |
Why?
|
| Neurotoxins | 3 | 1997 | 29 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2002 | 21 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2002 | 21 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2004 | 156 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 290 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2004 | 434 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2006 | 648 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2004 | 123 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Diet, Western | 1 | 2023 | 81 | 0.050 |
Why?
|
| Silver Staining | 1 | 2002 | 17 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2022 | 90 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2002 | 83 | 0.050 |
Why?
|
| Hemangioendothelioma | 1 | 2002 | 15 | 0.050 |
Why?
|
| Primates | 1 | 2023 | 126 | 0.050 |
Why?
|
| Community Health Services | 1 | 2023 | 227 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 134 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2010 | 938 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1999 | 49 | 0.050 |
Why?
|
| Mesonephroma | 1 | 2001 | 1 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenases | 1 | 2001 | 12 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2001 | 46 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 67 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 268 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 132 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2003 | 183 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2671 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 1999 | 171 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 345 | 0.050 |
Why?
|
| Microsatellite Repeats | 2 | 1999 | 168 | 0.040 |
Why?
|
| Cattle | 2 | 2004 | 984 | 0.040 |
Why?
|
| Nonlinear Dynamics | 1 | 2002 | 88 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 153 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 138 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 200 | 0.040 |
Why?
|
| Carnitine | 1 | 2001 | 84 | 0.040 |
Why?
|
| Rare Diseases | 2 | 2013 | 104 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 1062 | 0.040 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2021 | 24 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 810 | 0.040 |
Why?
|
| Drug Synergism | 2 | 1999 | 382 | 0.040 |
Why?
|
| Pneumothorax | 1 | 2021 | 38 | 0.040 |
Why?
|
| Ranula | 1 | 2020 | 3 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 289 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2001 | 177 | 0.040 |
Why?
|
| Mouth Floor | 1 | 2020 | 7 | 0.040 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2001 | 76 | 0.040 |
Why?
|
| Horses | 1 | 2021 | 111 | 0.040 |
Why?
|
| Aluminum Compounds | 1 | 2000 | 5 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 611 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 327 | 0.040 |
Why?
|
| Zambia | 1 | 2020 | 57 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 307 | 0.040 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2000 | 1 | 0.040 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2000 | 6 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2021 | 164 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 48 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 118 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 1998 | 940 | 0.040 |
Why?
|
| Lactates | 1 | 2000 | 85 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2018 | 1357 | 0.040 |
Why?
|
| Basigin | 1 | 2000 | 25 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2020 | 86 | 0.040 |
Why?
|
| Mice, Nude | 2 | 1999 | 698 | 0.040 |
Why?
|
| Cell Division | 2 | 2000 | 794 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 172 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2002 | 215 | 0.040 |
Why?
|
| Myoepithelioma | 1 | 1999 | 4 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2004 | 317 | 0.040 |
Why?
|
| Remission Induction | 2 | 2010 | 288 | 0.040 |
Why?
|
| Culture Media | 1 | 2000 | 165 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2021 | 199 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2000 | 119 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 1999 | 16 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 1999 | 67 | 0.040 |
Why?
|
| Mass Screening | 1 | 2008 | 1287 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2000 | 305 | 0.040 |
Why?
|
| Equipment Design | 2 | 2002 | 522 | 0.040 |
Why?
|
| Substantia Innominata | 1 | 1998 | 1 | 0.040 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1999 | 17 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2022 | 530 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2013 | 3457 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1999 | 15 | 0.040 |
Why?
|
| Adenoma, Pleomorphic | 1 | 1998 | 11 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2023 | 427 | 0.040 |
Why?
|
| Anorectal Malformations | 1 | 2020 | 112 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 1998 | 6 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 565 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 1999 | 257 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 1999 | 81 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 196 | 0.040 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1998 | 6 | 0.040 |
Why?
|
| Biotinylation | 1 | 1998 | 32 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 1999 | 71 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 1998 | 58 | 0.040 |
Why?
|
| Histones | 1 | 2004 | 636 | 0.040 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1998 | 6 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2017 | 219 | 0.040 |
Why?
|
| Cholinergic Fibers | 1 | 1998 | 18 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 33 | 0.040 |
Why?
|
| Silicon | 1 | 1998 | 16 | 0.040 |
Why?
|
| Basal Ganglia Diseases | 1 | 1998 | 8 | 0.040 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1998 | 15 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2003 | 722 | 0.040 |
Why?
|
| Neurocognitive Disorders | 1 | 1998 | 26 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 1050 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 1998 | 40 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2019 | 209 | 0.030 |
Why?
|
| North America | 1 | 2018 | 313 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 1238 | 0.030 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2018 | 46 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 1430 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1998 | 83 | 0.030 |
Why?
|
| Pain | 1 | 2023 | 756 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1999 | 391 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2005 | 1991 | 0.030 |
Why?
|
| Base Sequence | 3 | 2010 | 2181 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2002 | 978 | 0.030 |
Why?
|
| Space Perception | 1 | 1998 | 80 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 1999 | 301 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 1998 | 91 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 500 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 2017 | 13 | 0.030 |
Why?
|
| Huntington Disease | 1 | 1998 | 57 | 0.030 |
Why?
|
| Pregnancy, Triplet | 1 | 2016 | 5 | 0.030 |
Why?
|
| Injections, Epidural | 1 | 2017 | 26 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2010 | 2139 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2018 | 125 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2000 | 274 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 43 | 0.030 |
Why?
|
| Peritoneum | 1 | 2017 | 44 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 697 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 879 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2003 | 767 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 327 | 0.030 |
Why?
|
| Microchemistry | 1 | 1996 | 20 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2018 | 109 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 2426 | 0.030 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 63 | 0.030 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1996 | 21 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 5757 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2017 | 124 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 2900 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 352 | 0.030 |
Why?
|
| Bilirubin | 1 | 2016 | 97 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 1993 | 29 | 0.030 |
Why?
|
| Propofol | 1 | 2017 | 73 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1996 | 19 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2017 | 195 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1996 | 25 | 0.030 |
Why?
|
| Phospholipids | 1 | 1998 | 223 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1998 | 167 | 0.030 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 1996 | 16 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 282 | 0.030 |
Why?
|
| Reference Standards | 1 | 1996 | 186 | 0.030 |
Why?
|
| Fentanyl | 1 | 2017 | 94 | 0.030 |
Why?
|
| Kidney | 2 | 2017 | 1468 | 0.030 |
Why?
|
| Caregivers | 1 | 2023 | 877 | 0.030 |
Why?
|
| Peroxides | 1 | 1995 | 19 | 0.030 |
Why?
|
| Maxilla | 1 | 1995 | 38 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 890 | 0.030 |
Why?
|
| Carcinoma | 1 | 1998 | 240 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 243 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 209 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2007 | 443 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 315 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2001 | 219 | 0.030 |
Why?
|
| Catalase | 1 | 1995 | 130 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 1998 | 243 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1995 | 133 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1995 | 79 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2006 | 1389 | 0.030 |
Why?
|
| Cell Fusion | 2 | 1992 | 51 | 0.030 |
Why?
|
| Dyskinesias | 1 | 2015 | 19 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 248 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 752 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 21 | 0.030 |
Why?
|
| Necrosis | 2 | 2010 | 246 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2014 | 45 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 842 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2015 | 103 | 0.030 |
Why?
|
| Fetal Diseases | 2 | 2010 | 173 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2014 | 78 | 0.030 |
Why?
|
| Gene Expression | 2 | 2015 | 1502 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1995 | 89 | 0.030 |
Why?
|
| Pharynx | 1 | 2014 | 59 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1994 | 45 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1066 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 405 | 0.030 |
Why?
|
| Nasal Bone | 1 | 2013 | 3 | 0.030 |
Why?
|
| Periosteum | 1 | 2013 | 12 | 0.030 |
Why?
|
| Muscles | 1 | 2015 | 326 | 0.030 |
Why?
|
| Intestine, Large | 1 | 1993 | 14 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1993 | 17 | 0.030 |
Why?
|
| Intestinal Atresia | 1 | 1993 | 15 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 557 | 0.030 |
Why?
|
| Nasal Obstruction | 1 | 2013 | 27 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1993 | 45 | 0.030 |
Why?
|
| Chromosome Banding | 3 | 1999 | 19 | 0.030 |
Why?
|
| Gestational Age | 2 | 2010 | 910 | 0.020 |
Why?
|
| Patient Participation | 1 | 2016 | 420 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1993 | 69 | 0.020 |
Why?
|
| Homeostasis | 1 | 1997 | 621 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2004 | 318 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2018 | 996 | 0.020 |
Why?
|
| Eosinophil Granule Proteins | 1 | 2012 | 21 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 377 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2017 | 561 | 0.020 |
Why?
|
| Lysophospholipase | 1 | 2012 | 10 | 0.020 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 26 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1994 | 231 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1502 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1992 | 45 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2017 | 574 | 0.020 |
Why?
|
| Burkitt Lymphoma | 1 | 1992 | 60 | 0.020 |
Why?
|
| Self Report | 1 | 2016 | 827 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1998 | 530 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 78 | 0.020 |
Why?
|
| Clinical Protocols | 2 | 2005 | 271 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 1992 | 44 | 0.020 |
Why?
|
| Cognition | 2 | 2013 | 1153 | 0.020 |
Why?
|
| Ions | 2 | 2005 | 70 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 2 | 2005 | 84 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2012 | 125 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 412 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 353 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 1993 | 194 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 786 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1991 | 171 | 0.020 |
Why?
|
| Blood Bactericidal Activity | 1 | 2010 | 36 | 0.020 |
Why?
|
| Splenectomy | 1 | 2011 | 62 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 1993 | 252 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2012 | 183 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 5778 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2023 | 2654 | 0.020 |
Why?
|
| Capillaries | 2 | 2005 | 108 | 0.020 |
Why?
|
| Colorado | 1 | 2021 | 4565 | 0.020 |
Why?
|
| Leigh Disease | 1 | 2010 | 21 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 136 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 342 | 0.020 |
Why?
|
| Thymectomy | 1 | 2010 | 15 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1994 | 506 | 0.020 |
Why?
|
| Forensic Pathology | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2010 | 30 | 0.020 |
Why?
|
| Superoxides | 1 | 2010 | 202 | 0.020 |
Why?
|
| Ferrous Compounds | 2 | 2001 | 23 | 0.020 |
Why?
|
| Meningoencephalitis | 1 | 2010 | 25 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 234 | 0.020 |
Why?
|
| Research Design | 1 | 1996 | 1139 | 0.020 |
Why?
|
| Vagina | 2 | 2002 | 187 | 0.020 |
Why?
|
| Brain Edema | 1 | 2010 | 61 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 108 | 0.020 |
Why?
|
| Nausea | 1 | 2010 | 111 | 0.020 |
Why?
|
| Receptors, Antigen | 1 | 1989 | 16 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2010 | 85 | 0.020 |
Why?
|
| Dizziness | 1 | 2010 | 82 | 0.020 |
Why?
|
| Myocardium | 1 | 2015 | 1002 | 0.020 |
Why?
|
| Hernia | 1 | 1989 | 11 | 0.020 |
Why?
|
| Vomiting | 1 | 2010 | 130 | 0.020 |
Why?
|
| Genes, ras | 1 | 1989 | 97 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 30 | 0.020 |
Why?
|
| Gliosis | 1 | 1989 | 28 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2012 | 425 | 0.020 |
Why?
|
| Adenoidectomy | 1 | 2009 | 72 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 389 | 0.020 |
Why?
|
| United States | 2 | 2023 | 14841 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2010 | 356 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 170 | 0.020 |
Why?
|
| Oncogenes | 1 | 1989 | 116 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 47 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2008 | 50 | 0.020 |
Why?
|
| Microscopy | 1 | 2010 | 152 | 0.020 |
Why?
|
| Fever | 1 | 2010 | 306 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2010 | 184 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2008 | 43 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 886 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 1043 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2010 | 245 | 0.020 |
Why?
|
| Pruritus | 1 | 2008 | 63 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2008 | 79 | 0.020 |
Why?
|
| Recurrence | 2 | 2003 | 1060 | 0.020 |
Why?
|
| Tonsillectomy | 1 | 2009 | 89 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2010 | 183 | 0.020 |
Why?
|
| Adenoma | 1 | 1990 | 230 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2010 | 253 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2010 | 294 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2007 | 30 | 0.020 |
Why?
|
| Paresis | 1 | 2007 | 30 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 1999 | 21 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 287 | 0.020 |
Why?
|
| Craniotomy | 1 | 2007 | 77 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 198 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2007 | 114 | 0.020 |
Why?
|
| Genotype | 2 | 2007 | 1916 | 0.020 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2006 | 45 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 134 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2006 | 82 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1999 | 30 | 0.020 |
Why?
|
| F2-Isoprostanes | 1 | 2005 | 21 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2005 | 33 | 0.020 |
Why?
|
| Indicator Dilution Techniques | 1 | 2005 | 11 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 1999 | 55 | 0.020 |
Why?
|
| Isotopes | 1 | 2005 | 33 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2007 | 142 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2005 | 21 | 0.010 |
Why?
|
| Mullerian Ducts | 1 | 2005 | 12 | 0.010 |
Why?
|
| Calcimycin | 2 | 1996 | 49 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1998 | 2253 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 5472 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 363 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 767 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 1092 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2004 | 29 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2005 | 489 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 752 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 2004 | 16 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2004 | 75 | 0.010 |
Why?
|
| Scrotum | 1 | 2004 | 27 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 95 | 0.010 |
Why?
|
| Abdominal Abscess | 1 | 2003 | 27 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 106 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2004 | 70 | 0.010 |
Why?
|
| Serotyping | 1 | 2003 | 32 | 0.010 |
Why?
|
| Cytochrome b Group | 1 | 2003 | 18 | 0.010 |
Why?
|
| Operon | 1 | 2003 | 64 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2004 | 142 | 0.010 |
Why?
|
| Acetylation | 1 | 2004 | 248 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 985 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 191 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 167 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2004 | 312 | 0.010 |
Why?
|
| Hematoma | 1 | 2003 | 53 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 410 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2004 | 136 | 0.010 |
Why?
|
| Testis | 1 | 2003 | 151 | 0.010 |
Why?
|
| Sports Equipment | 1 | 2002 | 9 | 0.010 |
Why?
|
| Virulence | 1 | 2003 | 267 | 0.010 |
Why?
|
| Jejunum | 1 | 2002 | 31 | 0.010 |
Why?
|
| Macrophages | 1 | 2010 | 1547 | 0.010 |
Why?
|
| Protective Devices | 1 | 2002 | 31 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2001 | 8 | 0.010 |
Why?
|
| Amniocentesis | 1 | 2001 | 25 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2002 | 75 | 0.010 |
Why?
|
| Compressive Strength | 1 | 2002 | 74 | 0.010 |
Why?
|
| Oligohydramnios | 1 | 2001 | 12 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 560 | 0.010 |
Why?
|
| Bile Ducts | 1 | 2002 | 71 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2008 | 754 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2002 | 142 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 122 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 2001 | 96 | 0.010 |
Why?
|
| Weight-Bearing | 1 | 2002 | 173 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 1007 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 934 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 304 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 2000 | 21 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 1272 | 0.010 |
Why?
|
| Epithelium | 1 | 2001 | 313 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2000 | 14 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2002 | 290 | 0.010 |
Why?
|
| Aneurysm | 1 | 2000 | 31 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 1396 | 0.010 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 1999 | 3 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2002 | 404 | 0.010 |
Why?
|
| Desmin | 1 | 1999 | 24 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 41 | 0.010 |
Why?
|
| Neuropsychology | 1 | 1999 | 37 | 0.010 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 1998 | 4 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 1999 | 18 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2001 | 243 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1999 | 52 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 173 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 794 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 5079 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1998 | 24 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1998 | 55 | 0.010 |
Why?
|
| Stearic Acids | 1 | 1998 | 15 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1998 | 232 | 0.010 |
Why?
|
| Oleic Acid | 1 | 1998 | 40 | 0.010 |
Why?
|
| Survivors | 1 | 2001 | 493 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1998 | 57 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1998 | 120 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1998 | 110 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 1972 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1998 | 77 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 2224 | 0.010 |
Why?
|
| Cadaver | 1 | 1998 | 296 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 1996 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 1998 | 68 | 0.010 |
Why?
|
| Microcirculation | 1 | 1998 | 149 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1998 | 141 | 0.010 |
Why?
|
| Propyl Gallate | 1 | 1997 | 1 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 159 | 0.010 |
Why?
|
| Ionophores | 1 | 1996 | 24 | 0.010 |
Why?
|
| Actins | 1 | 1999 | 416 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1998 | 147 | 0.010 |
Why?
|
| Lung | 1 | 2010 | 4060 | 0.010 |
Why?
|
| Dogs | 1 | 1998 | 413 | 0.010 |
Why?
|
| Salivary Glands, Minor | 1 | 1996 | 11 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2001 | 801 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1998 | 234 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1998 | 240 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2001 | 565 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1998 | 391 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 1998 | 180 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 84 | 0.010 |
Why?
|
| Aorta | 1 | 1998 | 417 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1998 | 470 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1998 | 443 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1998 | 501 | 0.010 |
Why?
|
| PAX7 Transcription Factor | 1 | 1994 | 13 | 0.010 |
Why?
|
| Research | 1 | 1998 | 451 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1994 | 36 | 0.010 |
Why?
|
| Forkhead Box Protein O1 | 1 | 1994 | 33 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 1994 | 191 | 0.010 |
Why?
|
| Fura-2 | 1 | 1993 | 12 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 1992 | 4 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1992 | 8 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1992 | 11 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1992 | 27 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1995 | 234 | 0.010 |
Why?
|
| Neomycin | 1 | 1992 | 7 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1992 | 13 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 73 | 0.010 |
Why?
|
| Lymphoma, T-Cell | 1 | 1991 | 25 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 665 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1991 | 175 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1992 | 169 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1991 | 10 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 68 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1991 | 87 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 1991 | 106 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 60 | 0.010 |
Why?
|
| Alleles | 1 | 1990 | 891 | 0.000 |
Why?
|